ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
TenX Keane Acquisition

TenX Keane Acquisition (TENKU)

44.00
0.00
(0.00%)
終了 12月26日 6:00AM
0.00
0.00
(0.00%)
取引時間後: -

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
44.00
買値
11.00
売値
40.01
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
時価総額
前日終値
44.00
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
6,370,000
配当利回り
-
PER
2.53
1 株当たり利益 (EPS)
0.38
歳入
-
純利益
2.42M

TenX Keane Acquisition について

Citius Oncology will serve as a platform to develop and commercialize novel targeted oncology therapies. In August 2024, its primary asset, LYMPHIR, was approved by the FDA for the treatment of adults with relapsed or refractory CTCL who had had at least one prior systemic therapy. Management estima... Citius Oncology will serve as a platform to develop and commercialize novel targeted oncology therapies. In August 2024, its primary asset, LYMPHIR, was approved by the FDA for the treatment of adults with relapsed or refractory CTCL who had had at least one prior systemic therapy. Management estimates the initial market for LYMPHIR currently exceeds 400 million, is growing, and is underserved by existing therapies. Robust intellectual property protections that span orphan drug designation, complex technology, trade secrets and pending patents for immuno-oncology use as a combination therapy with checkpoint inhibitors would further support Citius Oncology s competitive positioning. Citius Oncology is a publicly traded subsidiary of Citius Pharmaceuticals. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Blank Checks
ウェブサイト
本社
Dover, Delaware, USA
設立
2024

TENKU 最新ニュース

TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update

TenX Keane shareholders voted to approve the previously announced merger with Citius Oncology at an extraordinary general meeting held on August 2, 2024 Post-merger company expected to trade on...

TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals

TenX Keane shareholders voted to approve the previously announced merger with Citius Oncology at an extraordinary general meeting held on August 2, 2024 Post-merger company expected to trade on...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

TENKU - Frequently Asked Questions (FAQ)

What is the current TenX Keane Acquisition share price?
The current share price of TenX Keane Acquisition is US$ 44.00
How many TenX Keane Acquisition shares are in issue?
TenX Keane Acquisition has 6,370,000 shares in issue
What is the market cap of TenX Keane Acquisition?
The market capitalisation of TenX Keane Acquisition is USD 280.28M
What is the 1 year trading range for TenX Keane Acquisition share price?
TenX Keane Acquisition has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of TenX Keane Acquisition?
The price to earnings ratio of TenX Keane Acquisition is 2.53
What is the reporting currency for TenX Keane Acquisition?
TenX Keane Acquisition reports financial results in USD
What is the latest annual profit for TenX Keane Acquisition?
The latest annual profit of TenX Keane Acquisition is USD 2.42M
What is the registered address of TenX Keane Acquisition?
The registered address for TenX Keane Acquisition is 3500 SOUTH DUPONT HIGHWAY, DOVER, DELAWARE, 19901
What is the TenX Keane Acquisition website address?
The website address for TenX Keane Acquisition is www.citiusonc.com
Which industry sector does TenX Keane Acquisition operate in?
TenX Keane Acquisition operates in the BLANK CHECKS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BAOSBaosheng Media Group Holdings Ltd
US$ 7.10
(310.40%)
58.74M
HOURHour Loop Inc
US$ 4.40
(207.69%)
97.42M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
CREVCarbon Revolution Public Ltd
US$ 9.16
(135.48%)
26.95M
AVGRAvinger Inc
US$ 1.45
(125.72%)
107.53M
SLGLSol Gel Technologies Ltd
US$ 0.9798
(-40.62%)
3.07M
DRCTDirect Digital Holdings Inc
US$ 3.71
(-32.55%)
23.82M
CHEKCheck Cap Ltd
US$ 1.55
(-31.11%)
3.49M
SYTASiyata Mobile Inc
US$ 0.5178
(-30.83%)
2.63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15.47
(-30.38%)
147.98k
SVMHSRIVARU Holding Ltd
US$ 0.0338
(20.71%)
280.27M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
LITMSnow Lake Resources Ltd
US$ 0.5849
(52.84%)
181.22M
LCIDLucid Group Inc
US$ 3.20
(3.23%)
108.75M
RGTIRigetti Computing Inc
US$ 11.35
(3.56%)
108.38M

最近閲覧した銘柄

Delayed Upgrade Clock